Distillate Capital, an employee-owned investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be downloaded...
Keep Reading →
January 27 - Hedge Fund Investor Letters, News - Comments
In this article, we presented the 10 blue-chip dividend stocks hedge funds are buying. Click to skip ahead and see 5 Blue Chip Dividend Stocks Hedge Funds...
Keep Reading →
January 23 - Dividend Stocks, Hedge Funds, News - Comments
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Keep Reading →
December 14 - Hedge Funds, News - Comments
Introduction As Mr. Valuation, I find myself constantly reminding investors that value investing requires patience. However, value investing also requires...
Keep Reading →
November 10 - Business, Dividend Stocks, Stock Analysis - Comments
In this article we are going to use hedge fund sentiment as a tool and determine whether Amgen, Inc. (NASDAQ:AMGN) is a good investment right now. We...
Keep Reading →
October 26 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However...
Keep Reading →
September 1 - Hedge Funds, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Keep Reading →
July 7 - Hedge Funds, News - Comments
In this article we will check out the progression of hedge fund sentiment towards Amgen, Inc. (NASDAQ:AMGN) and determine whether it is a good investment...
Keep Reading →
May 27 - Hedge Funds, News - Comments
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Keep Reading →
April 24 - Hedge Funds, News - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we publish an article with the title “Recession...
Keep Reading →
March 11 - Hedge Funds, News - Comments
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly...
Keep Reading →
December 25 - Hedge Funds, News - Comments
We can judge whether Amgen, Inc. (NASDAQ:AMGN) is a good investment right now by following the lead of some of the best investors in the world and piggybacking...
Keep Reading →
November 28 - Hedge Funds, News - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Keep Reading →
October 9 - Hedge Funds, News - Comments
Ray Dalio Sees 25% Chance of Recession This Year and in 2020 (Bloomberg) Ray Dalio, the billionaire founder of the world’s largest hedge fund, said...
Keep Reading →
September 5 - Hedge Funds, Insider Trading - Comments
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by...
Keep Reading →
June 6 - Hedge Funds, News - Comments
It’s been a rather green day on Wall Street as all three major indexes are positive. The Dow Jones is up over 150 points while the S&P 500...
Keep Reading →
May 21 - News - Comments
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don...
Keep Reading →
March 26 - Hedge Funds, News - Comments
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the...
Keep Reading →
December 8 - Hedge Funds, News - Comments
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital. According to The Wall Street Journal, this...
Keep Reading →
December 28 - Hedge Funds, News, Quantitative Investing - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest...
Keep Reading →
November 24 - News - Comments
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in. These...
Keep Reading →
July 17 - Dividend Stocks, News - Comments
If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the...
Keep Reading →
July 6 - News - Comments
1. U.S. Stock Market: “U.S. stocks rose on Monday, boosted by technology shares and by defense companies, which rose after the United States and...
Keep Reading →
May 22 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha. The drug first...
Keep Reading →
March 20 - News, Stock Analysis - Comments
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc. (NASDAQ:AMGN), Esperion Therapeutics...
Keep Reading →
March 17 - Market Movers, News - Comments
As a healthcare-focused fund, Michael Castor‘s Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered...
Keep Reading →
March 3 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system....
Keep Reading →
February 23 - News, Stock Analysis - Comments
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen. The article has...
Keep Reading →
February 9 - News, Stock Analysis - Comments
Etelcalcetide, an Amgen, Inc. (NASDAQ:AMGN) drug that is meant to treat secondary hyperparathyroidism has been approved by the U.S. Food and Drug Administration...
Keep Reading →
February 8 - News, Stock Analysis - Comments
Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unrelated...
Keep Reading →
February 7 - News, Stock Analysis - Comments
What does 2017 hold for Amgen, Inc. (NASDAQ:AMGN) and can this pharmaceutical stock lend color to your equity portfolio? Here’s a look at what makes...
Keep Reading →
January 23 - News, Stock Analysis - Comments
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences...
Keep Reading →
December 23 - News, Stock Analysis - Comments
Michael Burry is one of the most well known hedge fund managers outside finance circles. Here is what we said about him in our previous article: “...
Keep Reading →
November 30 - Hedge Funds - Comments
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don...
Keep Reading →
November 23 - Hedge Funds, News - Comments
Third Avenue Management is a New York-based investment fund that uses a deep value investing strategy for stock selection. The fund was founded by Martin...
Keep Reading →
October 29 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September. According to the...
Keep Reading →
September 27 - Market Movers, News - Comments
Romosozumab (AKA romo) from Amgen Inc (NASDAQ:AMGN) and Belgium-based UCB, which is in its Phase III FRAME study is yet to achieve any regulatory approval...
Keep Reading →
September 20 - News, Stock Analysis - Comments
Coherus Biosciences Inc (NASDAQ:CHRS) submitted a biologics licensing application (BLA) for its lead biosimilar development candidate earlier this month...
Keep Reading →
August 16 - News, Stock Analysis - Comments
Given that it’s the middle of earnings season, it’s not surprising that many major companies are trending today. The market are in the red...
Keep Reading →
July 28 - Earnings Report, News - Comments
The biosimilar space is relatively young. Only across the last handful of of years has the FDA put firm regulatory processes in place for the approval...
Keep Reading →
July 12 - News, Stock Analysis - Comments
Paul Holland and Matthew Miller co-founded Glaxis Capital in 2005. The fund’s equity portfolio has remained fairly concentrated since the end of...
Keep Reading →
May 16 - Hedge Funds, News, Tech - Comments
The ten S&P 500 companies that have increased their dividend payout by the highest average annual rate during the last five years are analyzed in...
Keep Reading →
May 6 - Dividend Stocks, News, Stock Analysis - Comments
There are various reasons why corporate insiders might sell shares of their own companies. For instance, they may seek to diversify their holdings, buy...
Keep Reading →
May 4 - Dividend Stocks, Insider Trading, News - Comments
Billionaire Daniel S. Loeb founded activist hedge fund Third Point LLC in 1995. The $17 billion New York-based firm lost 1.4% in 2015, which was not necessarily...
Keep Reading →
April 24 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News - Comments
The market has been volatile as the Federal Reserve winds down its easy money policies. Small cap stocks have been hit hard as a result, as the Russell...
Keep Reading →
March 7 - Hedge Funds, News - Comments
Biotech has undoubtedly been one of the most cherished industries, among hedge funds over the last few years and it’s not hard to understand why...
Keep Reading →
December 20 - Hedge Funds, News - Comments
With crude futures failing to rally past a key technical resistance level, shares of Sunedison Inc (NYSE:SUNE), SolarCity Corp (NASDAQ:SCTY),Solaredge...
Keep Reading →
December 16 - Market Movers, News - Comments
The market has been volatile as the Federal Reserve winds down its easy money policies. Small cap stocks have been hit hard as a result, as the Russell...
Keep Reading →
December 5 - Hedge Funds, News - Comments
Billionaire activist investor Dan Loeb of Third Point saw his hedge fund post losses of 8.9% for the September quarter in comparison to the S&P 500...
Keep Reading →
November 19 - Hedge Fund Analysis, Hedge Funds, News - Comments
Billionaire investor Dan Loeb, the founder of activist hedge fund Third Point LLC, discussed the performance of his investment firm, including the broader...
Keep Reading →
November 16 - Hedge Fund Analysis, Hedge Funds, Macroeconomic Predictions, News - Comments